Competitors of TTK Healthcare Ltd in the Pharmaceuticals Sector
Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
---|---|---|---|---|---|---|---|---|---|
Gujarat Themis Biosyn Ltd | 3,538 Cr. | 325 | 390/108 | 64.7 | 18.5 | 0.21 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 59.6 Cr. | 80.3 | 92.8/19.6 | 40.8 | 9.58 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 27.2 Cr. | 18.6 | 18.8/7.60 | 160 | 5.00 | 0.00 % | 4.06 % | 3.33 % | 10.0 |
Godavari Drugs Ltd | 96.6 Cr. | 128 | 155/82.1 | 15.0 | 51.8 | 0.00 % | 12.7 % | 15.5 % | 10.0 |
Glenmark Life Sciences Ltd | 13,870 Cr. | 1,126 | 1,335/609 | 31.0 | 190 | 2.00 % | 28.1 % | 21.1 % | 2.00 |
Gennex Laboratories Ltd | 490 Cr. | 21.6 | 29.0/10.2 | 32.7 | 7.24 | 0.00 % | 14.4 % | 10.4 % | 1.00 |
Ganga Pharmaceuticals Ltd | 7.61 Cr. | 15.7 | 28.5/10.8 | 152 | 13.3 | 0.00 % | 3.19 % | 0.84 % | 10.0 |
Fredun Pharmaceuticals Ltd | 360 Cr. | 765 | 1,054/650 | 20.7 | 255 | 0.09 % | 17.6 % | 15.0 % | 10.0 |
Fervent Synergies Ltd | 55.8 Cr. | 18.6 | 27.8/14.6 | 10.1 | 0.00 % | 34.8 % | 34.9 % | 10.0 | |
Fermenta Biotech Ltd | 912 Cr. | 310 | 332/144 | 98.2 | 0.40 % | 3.20 % | 5.59 % | 5.00 | |
Fabino Enterprises Ltd | 5.63 Cr. | 26.8 | 43.8/23.6 | 113 | 19.8 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
Evoq Remedies Ltd | 21.0 Cr. | 8.44 | 19.4/7.72 | 46.7 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
Everest Organics Ltd | 101 Cr. | 126 | 184/110 | 49.7 | 0.00 % | 6.03 % | 0.30 % | 10.0 | |
Murae Organisor Ltd | 33.6 Cr. | 1.36 | 3.10/0.95 | 2.26 | 0.00 % | 0.79 % | 0.13 % | 2.00 | |
Dipna Pharmachem Ltd | 17.9 Cr. | 7.45 | 16.2/7.00 | 16.4 | 15.6 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 16.3 Cr. | 16.2 | 25.8/14.4 | 74.2 | 21.6 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
Coral Laboratories Ltd | 310 Cr. | 868 | 999/262 | 13.6 | 497 | 0.23 % | 12.6 % | 9.58 % | 10.0 |
Concord Drugs Ltd | 37.5 Cr. | 37.5 | 61.5/30.1 | 33.8 | 0.00 % | 4.50 % | 1.29 % | 10.0 | |
Colinz Laboratories Ltd | 23.6 Cr. | 51.7 | 84.4/35.2 | 46.3 | 19.6 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
Cian Healthcare Ltd | 11.8 Cr. | 4.74 | 26.5/4.43 | 47.4 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 10.5 Cr. | 69.7 | 94.7/31.0 | 9.68 | 85.3 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
Checkpoint Trends Ltd | 8.65 Cr. | 15.8 | 17.4/4.09 | 78.7 | 0.97 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
Chandra Bhagat Pharma Ltd | 53.6 Cr. | 71.0 | 160/63.0 | 35.0 | 38.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
Brawn Biotech Ltd | 6.00 Cr. | 20.0 | 27.8/14.6 | 16.9 | 0.00 % | 25.9 % | 21.8 % | 10.0 | |
Bharat Immunological & Biological Corporation Ltd | 114 Cr. | 26.5 | 43.9/22.5 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
Beryl Drugs Ltd | 19.8 Cr. | 38.9 | 46.0/19.4 | 32.9 | 17.6 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
BDH Industries Ltd | 188 Cr. | 326 | 408/162 | 19.2 | 108 | 1.38 % | 20.6 % | 16.9 % | 10.0 |
Bacil Pharma Ltd | 21.5 Cr. | 36.5 | 36.5/4.68 | 2.07 | 0.00 % | 13.1 % | 13.8 % | 10.0 | |
Aurobindo Pharma Ltd | 86,016 Cr. | 1,469 | 1,593/835 | 24.0 | 509 | 0.31 % | 14.1 % | 11.5 % | 1.00 |
Auro Laboratories Ltd | 155 Cr. | 248 | 307/105 | 19.9 | 67.3 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
Anuh Pharma Ltd | 1,018 Cr. | 203 | 265/124 | 17.6 | 58.1 | 1.23 % | 25.6 % | 19.5 % | 5.00 |
ANG Lifesciences India Ltd | 64.1 Cr. | 49.1 | 86.1/44.5 | 59.0 | 0.00 % | 1.78 % | 8.72 % | 10.0 | |
Ami Organics Ltd | 6,526 Cr. | 1,596 | 1,823/1,004 | 102 | 183 | 0.19 % | 16.0 % | 9.37 % | 10.0 |
Amerise Biosciences Ltd | 5.75 Cr. | 0.87 | 0.94/0.54 | 0.81 | 0.00 % | 2.73 % | 2.75 % | 1.00 | |
Ambalal Sarabhai Enterprises Ltd | 444 Cr. | 57.9 | 77.7/35.3 | 37.7 | 17.9 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
Adline Chem Lab Ltd | 15.2 Cr. | 26.0 | 29.0/11.9 | 2.92 | 0.00 % | % | % | 10.0 | |
Achyut Healthcare Ltd | 109 Cr. | 65.0 | 71.9/40.2 | 192 | 18.3 | 0.00 % | 3.27 % | 2.52 % | 10.0 |
Abbott India Ltd | 60,318 Cr. | 28,372 | 30,521/21,907 | 48.7 | 1,741 | 1.45 % | 46.0 % | 34.9 % | 10.0 |
Aarti Pharmalabs Ltd | 5,584 Cr. | 616 | 722/371 | 24.8 | 194 | 0.49 % | 16.6 % | 13.1 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 180 Cr. | 66.6 | 75.8/37.0 | 27.5 | 46.6 | 0.00 % | 6.18 % | 3.81 % | 10.0 |
Zota Health Care Ltd | 1,643 Cr. | 619 | 725/395 | 34.8 | 0.16 % | 7.32 % | 16.8 % | 10.0 | |
Wockhardt Ltd | 16,201 Cr. | 1,055 | 1,127/213 | 219 | 0.00 % | 0.83 % | 12.1 % | 5.00 | |
Wanbury Ltd | 806 Cr. | 247 | 291/85.0 | 29.9 | 6.70 | 0.00 % | 62.5 % | % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | 21.3 | 0.00 % | 51.5 % | 163 % | 2.00 | |
Venus Remedies Ltd | 462 Cr. | 346 | 430/230 | 16.2 | 365 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
Unichem Laboratories Ltd | 5,144 Cr. | 732 | 755/399 | 336 | 0.00 % | 0.39 % | 1.17 % | 2.00 | |
TTK Healthcare Ltd | 2,337 Cr. | 1,661 | 1,923/1,178 | 36.8 | 708 | 0.60 % | 8.67 % | 6.43 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,15,017 Cr. | 3,397 | 3,591/1,823 | 68.7 | 203 | 0.82 % | 23.2 % | 24.2 % | 5.00 |
Themis Medicare Ltd | 2,473 Cr. | 269 | 304/142 | 49.4 | 41.0 | 0.19 % | 13.5 % | 11.8 % | 1.00 |
Syncom Formulations (India) Ltd | 1,920 Cr. | 20.4 | 27.9/7.25 | 71.0 | 3.05 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
Suven Pharmaceuticals Ltd | 31,846 Cr. | 1,250 | 1,289/541 | 132 | 80.6 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 2,887 Cr. | 133 | 169/60.8 | 12.4 | 0.00 % | 36.4 % | 36.3 % | 1.00 | |
Sun Pharmaceuticals Industries Ltd | 4,53,498 Cr. | 1,890 | 1,960/1,068 | 43.0 | 265 | 0.71 % | 17.3 % | 16.7 % | 1.00 |
Solara Active Pharma Sciences Ltd | 3,477 Cr. | 804 | 830/264 | 195 | 0.00 % | 8.67 % | 33.5 % | 10.0 | |
SMS Pharmaceuticals Ltd | 2,821 Cr. | 333 | 398/112 | 50.0 | 64.0 | 0.12 % | 11.4 % | 9.53 % | 1.00 |
SMS Lifesciences India Ltd | 460 Cr. | 1,537 | 1,750/464 | 27.8 | 585 | 0.10 % | 6.89 % | 3.66 % | 10.0 |
Shilpa Medicare Ltd | 8,404 Cr. | 859 | 960/296 | 205 | 208 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
Sequent Scientific Ltd | 4,862 Cr. | 195 | 241/90.7 | 227 | 26.3 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
Sanofi India Ltd | 15,832 Cr. | 6,877 | 7,600/4,449 | 32.2 | 298 | 2.43 % | 71.1 % | 51.5 % | 10.0 |
RPG Life Sciences Ltd | 4,632 Cr. | 2,798 | 2,977/1,290 | 50.2 | 227 | 0.57 % | 34.6 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 8,653 Cr. | 5,207 | 5,643/4,637 | 40.2 | 324 | 0.96 % | 44.9 % | 33.4 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 134 Cr. | 38.0 | 79.2/35.4 | 20.4 | 0.00 % | 27.6 % | 16.8 % | 10.0 | |
Pfizer Ltd | 26,455 Cr. | 5,788 | 6,453/3,834 | 43.9 | 786 | 0.60 % | 22.0 % | 16.1 % | 10.0 |
Par Drugs & Chemicals Ltd | 295 Cr. | 239 | 325/190 | 20.2 | 69.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
Panacea Biotec Ltd | 2,143 Cr. | 352 | 367/112 | 137 | 0.00 % | 3.57 % | 3.17 % | 1.00 | |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
Orchid Pharma Ltd | 6,780 Cr. | 1,336 | 1,592/432 | 60.8 | 231 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
Neuland Laboratories Ltd | 19,741 Cr. | 15,441 | 16,525/3,611 | 61.6 | 1,000 | 0.09 % | 33.3 % | 26.4 % | 10.0 |
Nectar Lifescience Ltd | 836 Cr. | 37.5 | 56.5/21.2 | 136 | 47.7 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 24,883 Cr. | 1,389 | 1,639/724 | 15.2 | 327 | 0.68 % | 30.1 % | 25.9 % | 2.00 |
Morepen Laboratories Ltd | 4,974 Cr. | 90.8 | 101/31.3 | 42.3 | 16.6 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
Marksans Pharma Ltd | 13,366 Cr. | 295 | 329/97.4 | 40.2 | 45.6 | 0.20 % | 20.6 % | 16.5 % | 1.00 |
Mangalam Drugs and Organics Ltd | 191 Cr. | 121 | 145/85.2 | 60.3 | 89.9 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
Lyka Labs Ltd | 542 Cr. | 152 | 173/97.9 | 589 | 17.9 | 0.00 % | 3.95 % | 6.61 % | 10.0 |
Lupin Ltd | 1,00,177 Cr. | 2,195 | 2,312/1,113 | 44.3 | 314 | 0.36 % | 15.7 % | 14.1 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,334 Cr. | 666 | 814/471 | 13.6 | 296 | 0.27 % | 22.3 % | 16.8 % | 10.0 |
Laurus Labs Ltd | 25,909 Cr. | 480 | 518/349 | 108 | 78.1 | 0.17 % | 7.50 % | 5.43 % | 2.00 |
Kwality Pharmaceuticals Ltd | 849 Cr. | 818 | 865/320 | 26.4 | 218 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 183 Cr. | 85.0 | 122/60.0 | 55.3 | 0.00 % | 19.0 % | % | 10.0 | |
Kopran Ltd | 1,446 Cr. | 300 | 370/185 | 24.4 | 102 | 1.00 % | 13.8 % | 11.0 % | 10.0 |
Kilitch Drugs (India) Ltd | 535 Cr. | 333 | 470/248 | 52.6 | 110 | 0.00 % | 12.8 % | 7.83 % | 10.0 |
Jubilant Pharmova Ltd | 19,566 Cr. | 1,228 | 1,247/319 | 83.6 | 341 | 0.41 % | 6.74 % | 0.76 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 29,597 Cr. | 1,906 | 2,030/1,244 | 50.4 | 188 | 0.64 % | 24.6 % | 20.0 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,190 Cr. | 449 | 496/270 | 52.3 | 70.9 | 1.11 % | 17.0 % | 13.0 % | 5.00 |
Ipca Laboratories Ltd | 42,005 Cr. | 1,656 | 1,709/933 | 79.2 | 250 | 0.24 % | 12.8 % | 9.35 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,541 Cr. | 433 | 538/331 | 21.4 | 274 | 1.16 % | 12.3 % | 8.68 % | 10.0 |
Indoco Remedies Ltd | 3,183 Cr. | 345 | 417/286 | 47.5 | 120 | 0.43 % | 10.4 % | 8.33 % | 2.00 |
Glenmark Pharmaceuticals Ltd | 50,270 Cr. | 1,781 | 1,831/702 | 278 | 0.14 % | 12.3 % | 50.9 % | 1.00 | |
Glaxosmithkline Pharmaceuticals Ltd | 45,271 Cr. | 2,672 | 3,088/1,385 | 58.8 | 105 | 1.20 % | 51.3 % | 37.3 % | 10.0 |
Dr Reddys Laboratories Ltd | 1,11,989 Cr. | 6,711 | 7,107/5,206 | 20.1 | 1,694 | 0.60 % | 26.5 % | 21.4 % | 5.00 |
Dishman Carbogen Amcis Ltd | 2,945 Cr. | 188 | 283/133 | 359 | 0.00 % | 0.02 % | 2.64 % | 2.00 | |
Cipla Ltd | 1,26,158 Cr. | 1,562 | 1,702/1,132 | 28.4 | 331 | 0.83 % | 22.8 % | 16.8 % | 2.00 |
Caplin Point Laboratories Ltd | 14,516 Cr. | 1,910 | 2,159/950 | 30.4 | 276 | 0.26 % | 26.5 % | 24.2 % | 2.00 |
Brooks Laboratories Ltd | 378 Cr. | 144 | 186/72.5 | 25.0 | 0.00 % | 24.7 % | 28.1 % | 10.0 | |
Bliss GVS Pharma Ltd | 1,347 Cr. | 128 | 150/77.4 | 12.6 | 92.4 | 0.39 % | 14.4 % | 10.2 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 121 Cr. | 74.1 | 92.0/42.6 | 191 | 11.2 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
Biocon Ltd | 41,619 Cr. | 347 | 396/218 | 26.6 | 165 | 0.14 % | 5.96 % | 5.25 % | 5.00 |
Beta Drugs Ltd | 1,920 Cr. | 1,997 | 2,010/892 | 52.7 | 163 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
Bal Pharma Ltd | 214 Cr. | 134 | 158/81.2 | 28.4 | 43.4 | 0.89 % | 12.1 % | 11.1 % | 10.0 |
Bafna Pharmaceuticals Ltd | 189 Cr. | 80.0 | 113/73.2 | 300 | 34.2 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
Astrazeneca Pharma India Ltd | 19,124 Cr. | 7,650 | 8,140/4,050 | 146 | 285 | 0.31 % | 31.1 % | 22.9 % | 2.00 |
Amrutanjan Health Care Ltd | 2,273 Cr. | 786 | 863/556 | 53.4 | 99.8 | 0.59 % | 21.3 % | 15.5 % | 1.00 |
Alpa Laboratories Ltd | 249 Cr. | 118 | 145/69.6 | 13.2 | 77.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
Alkem Laboratories Ltd | 72,866 Cr. | 6,094 | 6,440/3,510 | 34.0 | 862 | 0.66 % | 19.7 % | 19.6 % | 2.00 |
Alembic Pharmaceuticals Ltd | 23,400 Cr. | 1,190 | 1,304/707 | 37.2 | 245 | 0.92 % | 13.1 % | 13.3 % | 2.00 |
Albert David Ltd | 796 Cr. | 1,393 | 1,754/791 | 11.2 | 671 | 0.83 % | 27.8 % | 21.7 % | 10.0 |
Ajanta Pharma Ltd | 41,709 Cr. | 3,339 | 3,486/1,650 | 48.8 | 283 | 1.08 % | 31.6 % | 23.2 % | 2.00 |
Advanced Enzyme Technologies Ltd | 5,625 Cr. | 503 | 571/291 | 38.0 | 118 | 1.01 % | 15.2 % | 11.2 % | 2.00 |
Aarti Drugs Limited | 4,637 Cr. | 504 | 635/430 | 35.9 | 128 | 0.20 % | 13.7 % | 12.4 % | 10.0 |
Industry Average | 20,706.81 Cr | 1,312.51 | 64.28 | 186.46 | 0.29% | 16.78% | 15.93% | 6.64 |
About the Author
Getaka
Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.